VectivBio Holding AG EBIT

VectivBio Holding AG (VECT) currently reports a EBIT of $-94M as of December 2022. That compares with $-66M in the prior-year period — down 41.4% year over year. That is below the Healthcare sector average of $110B. Use the charts on this page to explore VectivBio Holding AG's EBIT history and peer comparisons.

VectivBio Holding AG's EBIT decreased from $-66M to $-94M — a 41.4% year-over-year decrease (period ending December 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

VectivBio Holding AG's EBIT of $-94M is lower than the Healthcare sector average of $110B. That is roughly 100.1% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

VectivBio Holding AG reported $-94M in EBIT as of December 2022. That compares with $-66M in the prior-year period — down 41.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current EBIT of $-94M, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $110B. From there, open related valuation or income-statement pages for VectivBio Holding AG, and consider following VECT for alerts when major investors trade the stock.